Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens. - Wikidata - wikimedia - TriplyDB

Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

http://www.wikidata.org/entity/Q34450382

about

Staphylococcus aureus α-toxin: nearly a century of intrigue Will there ever be a universal Staphylococcus aureus vaccine?Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus.Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.Adaptive Immunity Against Staphylococcus aureus.An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.Comparative Exoproteomics and Host Inflammatory Response in Staphylococcus aureus Skin and Soft Tissue Infections, Bacteremia, and Subclinical Colonization.Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells.An immunological assay for identification of potential biofilm-associated antigens of Staphylococcus aureus.The exceptionally broad-based potential of active and passive vaccination targeting the conserved microbial surface polysaccharide PNAG Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.Diversity of Virulence Factors Associated with West Australian Methicillin-Sensitive Staphylococcus aureus Isolates of Human Origin.Relative distribution of virulence-associated factors among Australian bovine Staphylococcus aureus isolates: Potential relevance to development of an effective bovine mastitis vaccine.Perspectives on vaccination in adults.Potential targets for next generation anti-microbial glycoconjugate vaccines.Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases.

P2860

Q26823686-4B03D6FE-AA9E-482B-B519-1DC5B085EA17 Q26824837-C13F0BD3-97C6-4F7C-93DF-5566C561515D Q30415823-A00A50A5-B566-4DB3-87E5-17F19CE11213 Q34595644-EC91E1FA-9F35-485B-A8AF-40B1DB59EDBC Q35439724-8E85FA5E-5CA1-4A82-8887-55C55133C90A Q35772579-45280602-24D3-42B3-839E-DBFABB79AF20 Q35919380-5BE72BD7-DB5C-433E-9737-CEE5AFF973F6 Q36609408-9914A6FE-FA4C-4516-B604-6ABF9D327616 Q37312140-FFCA5A74-4B23-4E7A-B123-8E0B09B47BC1 Q38494482-7846E630-FBEA-47D9-A34A-6E4409C09D64 Q38741540-6E3953A4-75D8-484D-955B-790D95842CBB Q38751767-5D5D1A79-1E8B-4554-9C64-7AFC0DF4A18F Q39093233-40F2DDE8-DBE8-4804-A677-F6BDDFC58C01 Q40028798-32CECC86-B3EE-49F3-A5AD-1DB4FBA8089D Q40245675-179E91E2-53D8-4771-BCEA-BA0A420E3930 Q40392346-9A0FFF91-78B7-434E-92ED-E8542DE50C9E Q40702476-DF0EE409-F956-47A4-8D0A-18CA0BEF1446 Q40776497-3A81D1F3-A856-4E37-9E38-4D1B7556FFF0 Q41117685-8D6E2E27-7984-4660-AACD-C74B49EEB63F Q42770328-C8BF7241-FC40-4290-8544-DD36045E8F82 Q43226506-5F97B95A-E338-4335-BCC4-1F5ED92D6763 Q43497830-E8FF586F-7924-4FC4-934A-95EB1E89310E Q53701548-AFFF5918-24B9-4A8D-B650-957E80163941 Q53702468-E8003F4B-E72C-47A6-93B7-DF1C519D2014

P2860

Opsonic and protective properties of antibodies raised to conjugate vaccines targeting six Staphylococcus aureus antigens.

http://www.wikidata.org/entity/Q34450382

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Opsonic and protective propert ...... taphylococcus aureus antigens.

@ast

Opsonic and protective propert ...... taphylococcus aureus antigens.

@en

Opsonic and protective propert ...... taphylococcus aureus antigens.

@nl

type

label

Opsonic and protective propert ...... taphylococcus aureus antigens.

@ast

Opsonic and protective propert ...... taphylococcus aureus antigens.

@en

Opsonic and protective propert ...... taphylococcus aureus antigens.

@nl

prefLabel

Opsonic and protective propert ...... taphylococcus aureus antigens.

@ast

Opsonic and protective propert ...... taphylococcus aureus antigens.

@en

Opsonic and protective propert ...... taphylococcus aureus antigens.

@nl

P1433

Q34450382-47F07C18-91F8-4794-9D4A-92F9642197E8

P1476

Q34450382-6A342456-189A-4839-BD4A-E6165BFE6137

P2093

Q34450382-360D543F-FD96-4CB2-A6CF-365CFDDDA263

Q34450382-37FEA4F9-F38E-441A-BD39-5BBBA78EB78F

Q34450382-825DA9E3-EF17-4C90-B4BF-FBEC62F5C36B

Q34450382-8AAF9C76-188C-47A8-B56F-5FBD86D97EB5

P2860

Q34450382-000B9B1F-E4D1-4209-A403-080BAC5D4C33

Q34450382-07978EDA-E77B-48E0-A73C-0D1825EB67D2

Q34450382-0FD087B3-92D4-4483-A25A-00EA6C554A7B

Q34450382-148935D6-2E37-4AB8-988C-877BEADADBA3

Q34450382-16FB6DE6-2F01-4F62-BC0C-B23BBD6774E7

Q34450382-1BD9C150-8521-41EB-8391-F1EC5AA38866

Q34450382-1C0803DB-4AF1-44B5-A62E-66B6F4D40BE9

Q34450382-1C5AA033-97A4-484D-8A96-E96488D6D526

Q34450382-1C6A90A1-1C11-4FF2-BB2F-EBED58B04B8B

Q34450382-21A1F314-6547-4F51-83F5-26F5C776F7FD

P304

Q34450382-462F74E9-B8E8-488E-9361-14ECB2505B76

P31

Q34450382-CA2ADBB4-EA38-4416-8230-C97472C11D24

P356

Q34450382-88A01676-003D-49B0-8459-E1573EABC6F0

P407

Q34450382-00739BF2-1975-4530-9DFB-CC157108B15B

P433

Q34450382-ACB09131-C852-40F2-A445-872C577B7D29

P478

Q34450382-8DA60124-1E90-4657-A73E-0AA6350ECB6B

P50

Q34450382-8FE0597D-995E-4D4C-B430-9808D00BD5A7

Q34450382-EEDA29CC-B881-4A56-BB5E-3029A6811725

P577

Q34450382-2B5B0246-4BD5-4062-B3B5-A783F10A69E9

P5875

Q34450382-B76C9DA1-A533-456D-95BB-1D0F2086A4D1

P698

Q34450382-A23FE107-EF60-4530-A854-0E55E2AE215E

P921

Q34450382-A39C396E-F8DA-40E6-9D59-36447F1D588D

P932

Q34450382-763FFC57-695C-445D-BA3F-FA8C47779197

P356

JOURNAL.PONE.0046648

P1433

P1476

Opsonic and protective propert ...... Staphylococcus aureus antigens

@en

P2093

Clarissa Pozzi

http://www.w3.org/2001/XMLSchema#string

Katarzyna Wilk

http://www.w3.org/2001/XMLSchema#string

Marina Gening

http://www.w3.org/2001/XMLSchema#string

Nikolay Nifantiev

http://www.w3.org/2001/XMLSchema#string

P2860

Conjugate vaccines for preventing Haemophilus influenzae type B infections

Vaccine protection against Staphylococcus aureus pneumonia

Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Development of a vaccine against Staphylococcus aureus

Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands

Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection

The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation.

Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens

Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.

P304

e46648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0046648

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232281756

http://www.w3.org/2001/XMLSchema#string

P698

23077517

http://www.w3.org/2001/XMLSchema#string

P921

P932

3471903

http://www.w3.org/2001/XMLSchema#string